repro

header

repro


Home

Our Aim

Our Services

Contact Us

Repromed International of Pakistan

Store

Home Insemination

Intra-Uterine Insemination

Ovulation Prediction

Pregnancy Tests

Semen Collection

Semen Evaluation

Semen Shipping

Gender Selection

Ultrasound Supplies

Education

PGD Gender Selection

Products

Agents

Cyprus

Disclaimer

FAQ's

Become A Distributor

Distributor Links

Testimonials

Andrology Istitute of Pakistan

Preimplantation Genetic Diagnosis (PGD)

Repromed International based in Lexington, Kentucky, USA, together with the Andrology Institute of America and the International Institute for Gender Selection based in Lexington, Kentucky, USA, also and their partner clinics in Europe, are proud to offer Preimplantation Genetic Diagnosis (PGD) services to all our patients for gender selection (familiy balancing) and also to eliminate chromosomal abnormalities (genetic screening).

There are many different medical, social, economic or cultural circumstances which put couples under the most intense pressure to produce a child of a specific gender. Scientists have identified thousands of health problems where genes play a part and many gender-related medical disorders can be passed from parent to child.

Preimplantation Genetic Diagnosis (PGD) in conjunction with In-Vitro Fertilization (IVF) is a medical procedure which allows embryos to be tested for gender-related genetic conditions, prior to being placed in the womb, giving the best opportunity to select the gender of your baby. PGD involves tried and tested assisted conception techniques which are safe, reliable and ethically sound. In-vitro fertilization is now widely accepted and this forms the basis of our gender selection program.

PGD is beneficial when:

  • Either one of a couple carrying a single gene defect, by testing for specific genetic disorders
  • Women aged 35+, by testing for age-related chromosomal disorders
  • Younger women with repeated unexplained miscarriages, by testing for chromosomal disorders
  • Couples wanting to balance their family

Two days after fertilization, embryos consist of eight cells. Science is now so advanced, that at this stage is it possible to safely remove a single cell, analyze it for a range of gender-specific chromosomal disorders and ensure only unaffected embryos are implanted in the womb. This specialist technique is called Pre-implantation Genetic Diagnosis (PGD).

A single cell, carrying material used to support the foetus's development, is removed from the embryo and its chromosome structure is analyzed in carefully controlled laboratory conditions, with the X and Y chromosomes clearly distinguishable. The removal of a single cell does not damage the embryo's development in any way, and each embryo will continue to grow normally.

PGD is a helpful tool since babies born with chromosome abnormalities occur in:

  • 1 in 1,000 births in women aged 30 or younger
  • 1 in 350 births by 35
  • 1 in 100 births by 40
  • and ultimately 1 in 25 births by 45.

The purpose of PGD is to select only healthy embryos (for the chromosomes we can so far test for) for implantation in the hope of achieving more pregnancies, less spontaneous abortions and less affected offspring.

PGD is not devoid of risks but these are outweighed by the benefits. During the embryo biopsy, the risk of accidental damage to an embryo during removal of the cell(s) is very low - around 0.6%. Implantation rates might be detrimentally affected by embryo biopsy, although observation so far suggests this possibility is outweighed by the beneficial effect of PGD.

No part of the future foetus will be lacking because one or two cells are removed from the embryo about 3-4 days after fertilization. All the cells of the embryo remain able to develop normally on their own until about the fourth day, which means that each cell by itself can grow into a whole and perfect foetus. The procedure merely delays development for a few hours, after which the embryo reaches the same number of cells as before and continues its normal development. Studies indicate that embryo biopsy does not harm the embryos.

For more information about this new and exciting technology, please access the International Institute for Gender Selection's website (www.genderselection.biz). You may also the Andrology Insitute of America's website (www.aia-zavos.com) for any andrological inquiries.

At the Andrology Institute of America we can assist you with home insemination, we can prepare semen specimens for your insemination or even gender select a specimen to help you choose the gender of your child while doing home inseminations.  We are also offering on the internet, among others, the following services:

If you would like for one of our experts to contact you and provide you with further information concerning your request and possible mode of treatment, please click here. We will get back to you, as promptly as possible.

 

 

Home Semen Analysis

conceive

Repromed International

Request interview with Dr Zavos

   


Affiliates

The following websites are affiliated with Repromed International.


images/affiliates.gif

ZDLinc.biz

Dr Zavos in the news

Andrology Institute of America

Fertility Zone

Fert Mart

Ebay

Home Gender Selection

 

 Copyright © 2010 Repromed International

Totalserve HouseA
17, Gr. Xenopoulou Street
3106 Limassol, Cyprus
P.O Box 54425
3724 Limassol, Cyprus
dvs

SSL